February 6, 2024
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this notice is to rescind NOT-NS-24-038 "Notice of Change: Extension of PAR-21-234 "NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)", effective immediately. This notice has been replaced with NOT-NS-24-056 Notice of Change: Extension of PAR-21-234 NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed. NOT-NS-24-038 was published with the incorrect receipt dates. NOT-NS-24-056 reflects the correct receipt dates. A summary of the corrections are included below:
The following application due dates have been added: New Application Due Date: June 12, 2024, Resubmission Application Due Date: July 12, 2024, and AIDS Application Due Date: September 7, 2024. The Expiration date is September 8, 2024. Changes to the NOFO are shown below.
Application Due Date(s) |
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
AIDS Application Due Date(s) | Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. The first AIDS application due date for this FOA is May 7, 2021. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
Scientific Merit Review | Standard dates apply |
Advisory Council Review | Standard dates apply |
Earliest Start Date | Standard dates apply |
Expiration Date | September 8, 2024 |
Michelle Jones-London, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-451-7966
Email: [email protected]
Lauren Ullrich, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-451-7964
Email: [email protected]